rs1007616

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_012099.3(POLR1G):​c.*334T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.457 in 697,704 control chromosomes in the GnomAD database, including 78,446 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 19099 hom., cov: 29)
Exomes 𝑓: 0.45 ( 59347 hom. )

Consequence

POLR1G
NM_012099.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.198

Publications

23 publications found
Variant links:
Genes affected
POLR1G (HGNC:24219): (RNA polymerase I subunit G) Enables RNA binding activity. Predicted to be involved in transmembrane receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within rRNA transcription. Located in cytosol; mitochondrion; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2022]
ERCC1 (HGNC:3433): (ERCC excision repair 1, endonuclease non-catalytic subunit) The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
ERCC1 Gene-Disease associations (from GenCC):
  • cerebrooculofacioskeletal syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Cockayne syndrome type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-45409835-T-C is Benign according to our data. Variant chr19-45409835-T-C is described in ClinVar as Benign. ClinVar VariationId is 1275555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.732 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012099.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1G
NM_012099.3
MANE Select
c.*334T>C
3_prime_UTR
Exon 3 of 3NP_036231.1O15446-1
ERCC1
NM_001983.4
MANE Select
c.844-110A>G
intron
N/ANP_001974.1P07992-1
POLR1G
NM_001297590.3
c.*334T>C
3_prime_UTR
Exon 3 of 3NP_001284519.1O15446-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLR1G
ENST00000309424.8
TSL:1 MANE Select
c.*334T>C
3_prime_UTR
Exon 3 of 3ENSP00000310966.3O15446-1
ERCC1
ENST00000300853.8
TSL:1 MANE Select
c.844-110A>G
intron
N/AENSP00000300853.3P07992-1
ERCC1
ENST00000340192.11
TSL:1
c.772-110A>G
intron
N/AENSP00000345203.6P07992-2

Frequencies

GnomAD3 genomes
AF:
0.486
AC:
73232
AN:
150610
Hom.:
19075
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.624
Gnomad AMI
AF:
0.476
Gnomad AMR
AF:
0.567
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.752
Gnomad SAS
AF:
0.578
Gnomad FIN
AF:
0.361
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.473
GnomAD4 exome
AF:
0.449
AC:
245715
AN:
546986
Hom.:
59347
Cov.:
0
AF XY:
0.453
AC XY:
133607
AN XY:
295052
show subpopulations
African (AFR)
AF:
0.614
AC:
9204
AN:
14994
American (AMR)
AF:
0.663
AC:
21466
AN:
32366
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
7455
AN:
19326
East Asian (EAS)
AF:
0.722
AC:
22859
AN:
31646
South Asian (SAS)
AF:
0.568
AC:
34525
AN:
60798
European-Finnish (FIN)
AF:
0.373
AC:
17654
AN:
47276
Middle Eastern (MID)
AF:
0.437
AC:
1034
AN:
2364
European-Non Finnish (NFE)
AF:
0.383
AC:
118171
AN:
308550
Other (OTH)
AF:
0.450
AC:
13347
AN:
29666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
5903
11806
17708
23611
29514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.486
AC:
73302
AN:
150718
Hom.:
19099
Cov.:
29
AF XY:
0.489
AC XY:
35980
AN XY:
73520
show subpopulations
African (AFR)
AF:
0.624
AC:
25613
AN:
41028
American (AMR)
AF:
0.567
AC:
8578
AN:
15122
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1337
AN:
3470
East Asian (EAS)
AF:
0.752
AC:
3874
AN:
5150
South Asian (SAS)
AF:
0.576
AC:
2750
AN:
4772
European-Finnish (FIN)
AF:
0.361
AC:
3676
AN:
10196
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.383
AC:
25919
AN:
67686
Other (OTH)
AF:
0.476
AC:
996
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1633
3267
4900
6534
8167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.409
Hom.:
2502
Bravo
AF:
0.508
Asia WGS
AF:
0.659
AC:
2293
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.7
DANN
Benign
0.84
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1007616; hg19: chr19-45913093; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.